Measured Risk Portfolios »

Inhibrx Biosciences shares owned by Measured Risk Portfolios

Quarter-by-quarter ownership of Inhibrx Biosciences (INBX) shares owned by Measured Risk Portfolios from 13F filings

Historical chart of Measured Risk Portfolios investment in Inhibrx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx Biosciences held by Measured Risk Portfolios consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx Biosciences by Measured Risk Portfolios

Quarter filed Position value Share count Share price at filing
2024-12-31 $569 37 15.41

More positions owned by Measured Risk Portfolios

Spdr S&p 500 Etf Tr Call Call Option
Bondbloxx Etf Trust Bloomberg Six Mn (XHLF)
Sprouts Fmrs Mkt (SFM)
Apple (AAPL)
Goldman Sachs Etf Tr Acces Treasury (GBIL)
Clearway Energy CL C (CWEN)
United Parcel Service CL B (UPS)
Kinder Morgan (KMI)
Vaneck Etf Trust Preferred Securt (PFXF)
Verizon Communications (VZ)
Philip Morris International (PM)
Realty Income (O)
Vaneck Etf Trust Bdc Income Etf (BIZD)
Digital Realty Trust (DLR)
Duke Energy Corp Com New (DUK)

View all positions for Measured Risk Portfolios

Top funds holding Inhibrx Biosciences

Viking Global Investors
Perceptive Advisors
Sanofi
HighTower Advisors
BlackRock
Vanguard Group
Sofinnova Ventures
Woodline Partners
Millennium Management
Partner Fund Management
Caligan Partners
Geode Capital Management
State Street Corporation
Readystate Asset Management
Kennedy Capital Management

View all funds holding Inhibrx Biosciences